Pharmaline Saudia is a joint-venture agreement between Malia Group and Al Rashed Group in Saudi Arabia. Located on 60,000 sqm of land in King Abdullah Economic City (KAEC), a mega-project attracting world class companies in Riyadh, Pharmaline Saudi Arabia will be a GMP-compliant site intended to serve the lucrative markets of Saudi Arabia, the GCC and others. The plant is scheduled to begin operations early 2020. Malia Group and Pharmaline will be represented on the Board.